A Study of Sintilimab Combined With Chemotherapy for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma

NCT06463834 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER_GOV

Sponsor class

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Sintilimab

Sponsor

Fujian Cancer Hospital